Estradiol 0.075mg Patch (twice Wk)

Manufacturer MYLAN Active Ingredient Estradiol Transdermal Biweekly Patch(es tra DYE ole) Pronunciation es-tra-DYE-ol
WARNING: Do not use this drug to prevent heart disease or dementia. A study of women taking an estrogen with a progestin showed a raised chance of heart attack, stroke, blood clot, breast cancer, and dementia. The chance of stroke, blood clot, and dementia was also raised when the estrogen was taken alone. Not all products and doses were studied. It is not known if the same effects may happen with this drug.The chance of endometrial cancer may be raised with the use of estrogen alone in patients with a uterus. Use of a progestin along with estrogen may lower the risk. Call your doctor right away if you have unexplained or long-lasting vaginal bleeding.Use this drug for the shortest time needed at the lowest useful dose. Your doctor will talk with you on a regular basis to see if you need to keep taking this drug. @ COMMON USES: It is used to prevent soft, brittle bones (osteoporosis) after menopause.It is used to prevent or lower the signs of the change of life (menopause).It is used to add estrogen to the body when the ovaries have been taken out or do not work the right way.It may be given to you for other reasons. Talk with the doctor.
🏷️
Drug Class
Estrogen; Hormone Replacement Therapy (HRT)
🧬
Pharmacologic Class
Estrogen receptor agonist
🀰
Pregnancy Category
Category X
βœ…
FDA Approved
Sep 1986
βš–οΈ
DEA Schedule
Not Controlled

Overview

ℹ️

What is this medicine?

Estradiol is a hormone patch used to replace estrogen that your body no longer makes after menopause. It helps relieve symptoms like hot flashes and vaginal dryness, and can help prevent bone thinning. The patch is applied to your skin and releases the hormone slowly into your body.
πŸ“‹

How to Use This Medicine

Proper Use of This Medication

To use this medication correctly, follow your doctor's instructions and read all the information provided. It's essential to use this medication as directed.

Application Instructions

Apply this medication only to your skin, as directed by your doctor. Do not take it by mouth.
Keep the medication away from your mouth, nose, and eyes, as it may cause burning.
Apply the patch at the same time every day to maintain a consistent routine.
Before and after applying the patch, wash your hands thoroughly.
Choose a clean, dry, and healthy area of skin on your lower belly or upper buttocks to apply the patch. Rotate the application site with each new patch to avoid skin irritation.
Avoid applying a patch to the same site for at least 7 days.
Do not apply the patch to skin with any problems, such as cuts, wounds, or irritation.
Avoid applying the patch to the breast area.
Do not apply the patch to skin that has been treated with creams, oils, lotions, powder, or other skin products, as this may affect the patch's adhesion.
Choose a hair-free area of skin to apply the patch.
Avoid applying the patch to your waistline or areas where sitting may cause it to come off.
Do not cut or divide the patches, as this may affect their effectiveness.
Do not use damaged patches, as they may not work properly.

Managing Patch Adhesion

If the patch falls off, try to reapply it to the same area. If you're unable to reapply the patch, apply a new one to a different area.
Wear only one patch at a time to avoid overdose or increased side effects.

Disposing of Used Patches

After removing a used patch, fold the sticky sides together to prevent accidental exposure.
Dispose of used patches in a secure location where children and pets cannot access them.

Storage and Disposal

Store this medication at room temperature in a dry place, away from bathrooms and areas prone to moisture.
Keep the medication out of reach of children and pets.

Missed Dose

If you miss a dose, apply a new patch as soon as you remember, after removing the old one.
πŸ’‘

Lifestyle & Tips

  • Apply the patch to a clean, dry area of skin on your lower abdomen or buttocks. Avoid breasts, waistline, or areas with excessive hair or scars.
  • Rotate application sites to prevent skin irritation. Do not apply to the same spot twice in a row.
  • Press the patch firmly in place for about 10 seconds to ensure good adhesion.
  • If a patch falls off, try to reapply it. If it doesn't stick, apply a new patch and continue your regular schedule.
  • Do not cut the patch.
  • Avoid smoking, as it can increase the risk of serious side effects like blood clots.
  • Maintain a healthy diet and engage in regular weight-bearing exercise to support bone health.
  • Attend all scheduled doctor appointments and screenings (e.g., mammograms, pelvic exams).

Dosing & Administration

πŸ‘¨β€βš•οΈ

Adult Dosing

Standard Dose: Estradiol 0.075 mg patch applied topically to the lower abdomen or buttocks twice weekly (e.g., every 3-4 days).
Dose Range: 0.025 - 0.1 mg

Condition-Specific Dosing:

postmenopausal_vasomotor_symptoms: Initial dose typically 0.025 mg patch twice weekly, titrate as needed based on response and tolerability, up to 0.1 mg twice weekly. 0.075 mg is a common effective dose.
vulvar_and_vaginal_atrophy: Initial dose typically 0.025 mg patch twice weekly, titrate as needed.
hypoestrogenism_due_to_hypogonadism_oophorectomy_or_primary_ovarian_failure: Initial dose typically 0.025 mg patch twice weekly, titrate as needed based on clinical response and serum estradiol levels.
πŸ‘Ά

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established
Adolescent: Not established (except for specific conditions like primary ovarian failure, where dosing is individualized and typically lower than adult HRT doses, and not typically with transdermal patches of this strength for initial therapy).
βš•οΈ

Dose Adjustments

Renal Impairment:

Mild: No specific dose adjustment required, but use with caution due to potential for fluid retention.
Moderate: No specific dose adjustment required, but use with caution due to potential for fluid retention.
Severe: No specific dose adjustment required, but use with caution due to potential for fluid retention. Monitor for exacerbation of fluid retention.
Dialysis: No specific dose adjustment required, but use with caution. Estradiol is not significantly dialyzable.

Hepatic Impairment:

Mild: Use with caution. Transdermal route bypasses first-pass metabolism, but hepatic metabolism still occurs.
Moderate: Contraindicated in severe hepatic impairment. Use with extreme caution in moderate impairment; consider lower doses and close monitoring.
Severe: Contraindicated.
Note: Estrogens are extensively metabolized by the liver. Impaired liver function may lead to increased systemic exposure and adverse effects.

Pharmacology

πŸ”¬

Mechanism of Action

Estradiol is the primary estrogen secreted by the human ovary. It binds to and activates estrogen receptors (ERΞ± and ERΞ²) in target tissues, including the reproductive organs, breast, bone, and brain. This binding leads to a conformational change in the receptor, allowing it to interact with specific DNA sequences (estrogen response elements) and co-activator proteins, thereby regulating gene transcription and protein synthesis. In postmenopausal women, estrogen replacement alleviates symptoms of estrogen deficiency such as vasomotor symptoms and vulvar/vaginal atrophy, and helps prevent bone loss.
πŸ“Š

Pharmacokinetics

Absorption:

Bioavailability: Approximately 80% (transdermal, relative to oral, but highly variable due to first-pass bypass)
Tmax: Approximately 1-3 days (for steady-state plasma concentrations with transdermal patch)
FoodEffect: Not applicable for transdermal patch

Distribution:

Vd: Approximately 9-12 L/kg
ProteinBinding: Approximately 98% (primarily to sex hormone-binding globulin [SHBG] and albumin)
CnssPenetration: Limited (systemic estradiol crosses the blood-brain barrier, but the extent of direct CNS penetration for therapeutic effects is complex)

Elimination:

HalfLife: Approximately 1-2 hours (for circulating estradiol after removal of patch, but sustained release from patch provides continuous levels)
Clearance: Approximately 600-700 mL/min/kg
ExcretionRoute: Renal (primarily as glucuronide and sulfate conjugates)
Unchanged: <1%
⏱️

Pharmacodynamics

OnsetOfAction: Gradual (symptom relief typically within weeks)
PeakEffect: Achieved within 1-3 days of patch application, maintained throughout the dosing interval
DurationOfAction: Maintained for the duration of patch application (3-4 days for twice-weekly patches)

Safety & Warnings

⚠️

BLACK BOX WARNING

Estrogens and progestins should not be used for the prevention of cardiovascular disease or dementia. The Women's Health Initiative (WHI) study reported increased risks of myocardial infarction, stroke, invasive breast cancer, pulmonary emboli, and deep vein thrombosis in postmenopausal women (50-79 years of age) during 5.6 years of treatment with daily oral conjugated estrogens (0.625 mg) combined with medroxyprogesterone acetate (2.5 mg) relative to placebo. The WHI study also reported an increased risk of stroke and deep vein thrombosis in postmenopausal women (50-79 years of age) during 7.1 years of treatment with daily oral conjugated estrogens (0.625 mg) alone relative to placebo. The WHI Memory Study (WHIMS), an ancillary study of WHI, reported an increased risk of probable dementia in postmenopausal women 65 years of age or older during 4 years of treatment with daily oral conjugated estrogens plus medroxyprogesterone acetate and in postmenopausal women 65 years of age or older during 5.2 years of treatment with daily oral conjugated estrogens alone relative to placebo. These risks should be weighed against the benefits of estrogen therapy.
⚠️

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you experience any of the following symptoms, contact your doctor or seek medical attention immediately:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of liver problems, including:
+ Dark urine
+ Tiredness
+ Decreased appetite
+ Upset stomach or stomach pain
+ Light-colored stools
+ Vomiting
+ Yellow skin or eyes
Signs of gallbladder problems, such as:
+ Pain in the upper right belly area, right shoulder area, or between the shoulder blades
+ Yellow skin or eyes
+ Fever with chills
+ Bloating
+ Severe upset stomach or vomiting
Signs of pancreatitis (pancreas problem), including:
+ Severe stomach pain
+ Severe back pain
+ Severe upset stomach or vomiting
Signs of high blood pressure, such as:
+ Severe headache or dizziness
+ Passing out
+ Changes in eyesight
Weakness on one side of the body
Trouble speaking or thinking
Changes in balance
Drooping on one side of the face
Blurred eyesight
Eyesight changes or loss
Bulging eyes
Changes in how contact lenses feel
Breast lump, pain, or soreness
Nipple discharge
Vaginal itching or discharge
Abnormal vaginal bleeding
Depression or other mood changes
Memory problems or loss
Fever
Difficulty urinating or changes in urine output
Pain while urinating

This medication may cause fluid retention, leading to swelling or weight gain. If you experience swelling, weight gain, or trouble breathing, inform your doctor.

Blood Clots and High Calcium Levels

Seek immediate medical attention if you experience signs of a blood clot, such as:
Chest pain or pressure
Coughing up blood
Shortness of breath
Swelling, warmth, numbness, changes in color, or pain in a leg or arm
Trouble speaking or swallowing

High calcium levels can occur in some people with cancer taking this medication. If you experience signs of high calcium levels, such as:
Weakness
Confusion
Fatigue
Headache
Upset stomach or vomiting
Constipation
Bone pain
contact your doctor right away.

Other Possible Side Effects

Most people do not experience severe side effects, and some may have only minor side effects. If you experience any of the following side effects, contact your doctor or seek medical attention if they bother you or do not go away:
Dizziness or headache
Hair loss
Upset stomach or vomiting
Constipation
Stomach pain or cramps
Bloating
Enlarged or tender breasts
Vaginal bleeding or spotting
Painful periods
Signs of a common cold
Nose or throat irritation
Weight gain or loss
Joint pain
Leg cramps
Changes in sex interest
Irritation at the site of application

Reporting Side Effects

If you have questions about side effects or experience any side effects not listed here, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Sudden severe headache or migraine
  • Sudden vision changes (e.g., partial or complete loss of vision)
  • Numbness or weakness in an arm or leg, especially on one side of the body
  • Trouble speaking or understanding speech
  • Sudden chest pain, shortness of breath, or coughing up blood
  • Pain, swelling, or tenderness in one leg (especially the calf)
  • Yellowing of the skin or eyes (jaundice)
  • New lump in your breast or nipple discharge
  • Unusual vaginal bleeding or spotting after menopause
  • Severe abdominal pain
πŸ“‹

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances. Be sure to describe the allergic reaction and its symptoms.
A history of certain health conditions, such as:
+ Bleeding disorders
+ Blood clots or an increased risk of blood clots
+ Breast cancer
+ Liver problems or liver tumors
+ Heart attack
+ Stroke
+ Tumors that are sensitive to estrogen
Unexplained vaginal bleeding
Pregnancy or potential pregnancy. Note: This medication should not be taken during pregnancy.

This list is not exhaustive, and it is crucial to discuss all your medications (prescription, over-the-counter, natural products, and vitamins) and health issues with your doctor and pharmacist. They will help determine if it is safe to take this medication with your other medications and health conditions. Do not initiate, stop, or adjust the dosage of any medication without consulting your doctor first.
⚠️

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. Your doctor may advise you to stop taking this drug before certain surgical procedures, and if so, will instruct you on when to resume taking it after the surgery or procedure.

If you anticipate being immobile for extended periods, such as during long trips, bedrest after surgery, or illness, discuss this with your doctor, as prolonged inactivity may increase your risk of developing blood clots. Additionally, if you have diabetes (high blood sugar), it is crucial to closely monitor your blood sugar levels.

Be aware that medications like this one can cause high blood pressure. Follow your doctor's instructions for regular blood pressure checks. You should also have your blood work and bone density checked as directed by your doctor.

Regular breast exams and gynecology check-ups are vital, and you should also perform breast self-exams as instructed by your doctor. The risk of certain side effects, such as heart attack, stroke, breast cancer, ovarian cancer, and others, may vary depending on factors like the duration of estrogen use, whether it is taken with or without a progestin, and other individual factors. Discuss the benefits and risks of using this medication with your doctor.

High triglyceride levels have been associated with this drug, so inform your doctor if you have a history of elevated triglyceride levels. This medication may cause dark skin patches on your face, so it is essential to avoid sun exposure, sunlamps, and tanning beds, and use sunscreen and protective clothing and eyewear when going outside.

This medication may interfere with certain laboratory tests, so be sure to inform all your healthcare providers and lab personnel that you are taking this drug. Avoid smoking, as it increases the risk of heart disease, and limit your alcohol consumption. If you regularly consume grapefruit juice or eat grapefruit, discuss this with your doctor.

For optimal effectiveness, use this medication in conjunction with calcium and vitamin D supplements and engage in weight-bearing exercises, such as walking or physical therapy, as directed by your doctor. Adhere to the diet and exercise plan recommended by your doctor.

In some cases, this medication may affect growth in children and teenagers, so they may require regular growth checks. Discuss this with your doctor. If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects. Finally, if you are breastfeeding, consult your doctor to discuss any potential risks to your baby.
πŸ†˜

Overdose Information

Overdose Symptoms:

  • Nausea
  • Vomiting
  • Breast tenderness
  • Abdominal pain
  • Drowsiness/fatigue
  • Withdrawal bleeding (in women with an intact uterus)

What to Do:

Remove the patch. There is no specific antidote. Treatment is symptomatic and supportive. Contact a poison control center or seek immediate medical attention. Call 1-800-222-1222 (Poison Control).

Drug Interactions

🚫

Contraindicated Interactions

  • Aromatase inhibitors (e.g., Anastrozole, Letrozole, Exemestane) - concurrent use would counteract the effect of the aromatase inhibitor.
  • Tamoxifen (concurrent use may increase risk of thromboembolic events and alter efficacy of tamoxifen).
πŸ”΄

Major Interactions

  • CYP3A4 inducers (e.g., Rifampin, Carbamazepine, Phenytoin, Phenobarbital, St. John's Wort): May significantly decrease estradiol plasma concentrations, leading to reduced therapeutic effect and potential for breakthrough bleeding. Consider alternative therapies or dose adjustments.
  • CYP3A4 inhibitors (e.g., Ketoconazole, Itraconazole, Ritonavir, Clarithromycin, Grapefruit juice): May increase estradiol plasma concentrations, potentially increasing adverse effects. Monitor for increased estrogenic effects.
  • Thyroid hormone replacement (e.g., Levothyroxine): Estrogens can increase thyroid-binding globulin (TBG) levels, leading to increased circulating thyroid hormone and potentially increased thyroid hormone requirements. Monitor thyroid function and adjust thyroid hormone dose as needed.
  • Anticoagulants (e.g., Warfarin): Estrogens may decrease the anticoagulant effect of warfarin. Close monitoring of INR/PT is recommended, and warfarin dose adjustment may be necessary.
  • Lamotrigine: Estrogens can decrease lamotrigine plasma concentrations, potentially leading to loss of seizure control. Monitor lamotrigine levels and adjust dose as needed.
🟑

Moderate Interactions

  • Corticosteroids (e.g., Prednisone): Estrogens may decrease the hepatic clearance of corticosteroids, leading to increased plasma concentrations and enhanced effects. Monitor for corticosteroid toxicity.
  • Cyclosporine: Estrogens may inhibit the metabolism of cyclosporine, leading to increased plasma concentrations and potential for toxicity. Monitor cyclosporine levels.
  • Folic acid: Estrogens may interfere with folate metabolism.
  • Bosentan: May decrease estradiol levels.
🟒

Minor Interactions

  • Not available

Monitoring

πŸ”¬

Baseline Monitoring

Complete medical history and physical examination

Rationale: To identify contraindications, risk factors (e.g., cardiovascular disease, breast cancer, thromboembolic events), and establish baseline health status.

Timing: Prior to initiation of therapy

Blood pressure

Rationale: Estrogens can affect blood pressure.

Timing: Prior to initiation of therapy

Breast examination and mammography

Rationale: To screen for breast cancer, as estrogen therapy can increase risk.

Timing: Prior to initiation of therapy (and as clinically indicated)

Pelvic examination and Pap test

Rationale: To screen for gynecological conditions, including endometrial cancer (if uterus intact and not on progestin).

Timing: Prior to initiation of therapy (and as clinically indicated)

Lipid profile (total cholesterol, HDL, LDL, triglycerides)

Rationale: Estrogens can affect lipid metabolism.

Timing: Prior to initiation of therapy (if clinically indicated)

Liver function tests (LFTs)

Rationale: To assess hepatic function, as estrogens are metabolized by the liver.

Timing: Prior to initiation of therapy (if clinically indicated)

πŸ“Š

Routine Monitoring

Annual physical examination, including blood pressure, breast examination, and pelvic examination

Frequency: Annually

Target: Normal for age and health status

Action Threshold: Any significant change or abnormality requires further investigation.

Mammography

Frequency: As per national screening guidelines (e.g., annually or biennially)

Target: No suspicious findings

Action Threshold: Any new or suspicious findings require immediate follow-up.

Assessment of symptoms (e.g., vasomotor symptoms, vaginal atrophy)

Frequency: Regularly (e.g., every 3-6 months initially, then annually)

Target: Symptom control with lowest effective dose

Action Threshold: Persistent or worsening symptoms, or new adverse effects, may require dose adjustment or discontinuation.

Monitoring for signs of thromboembolic events, cardiovascular disease, and cancer

Frequency: Ongoing, at every visit

Target: Absence of signs/symptoms

Action Threshold: Immediate medical attention for any signs of DVT, PE, stroke, MI, or new breast lump/abnormal bleeding.

πŸ‘οΈ

Symptom Monitoring

  • Unusual vaginal bleeding or spotting
  • New breast lump or changes in breasts
  • Pain, swelling, or tenderness in one leg (signs of DVT)
  • Sudden chest pain, shortness of breath, or coughing up blood (signs of PE)
  • Sudden severe headache, dizziness, vision changes, slurred speech, weakness or numbness in an arm or leg (signs of stroke)
  • Chest pain or discomfort, pain radiating to arm, back, neck, jaw, or stomach, shortness of breath, cold sweat, nausea, lightheadedness (signs of MI)
  • Yellowing of skin or eyes (jaundice)
  • Severe abdominal pain
  • Mood changes, depression

Special Patient Groups

🀰

Pregnancy

Contraindicated. Estradiol is not indicated for use in pregnancy. There is no indication for estrogen therapy during pregnancy, and there is evidence of potential harm to the fetus. Exposure to estrogens during pregnancy has been associated with an increased risk of congenital anomalies in the reproductive organs of male and female fetuses.

Trimester-Specific Risks:

First Trimester: Potential for feminization of male fetuses and other reproductive tract abnormalities.
Second Trimester: Potential for feminization of male fetuses and other reproductive tract abnormalities.
Third Trimester: Potential for feminization of male fetuses and other reproductive tract abnormalities.
🀱

Lactation

Not recommended. Estradiol is excreted in human milk and may decrease milk production and quality. Potential adverse effects on the breastfed infant have been reported (e.g., jaundice, breast enlargement).

Infant Risk: L3 (Moderate risk) - Potential for adverse effects on the infant (e.g., jaundice, breast enlargement) and reduction in milk supply. Use should be avoided if possible.
πŸ‘Ά

Pediatric Use

Not indicated for use in pediatric patients for hormone replacement therapy, except in specific cases of primary ovarian failure or hypogonadism, where dosing is highly individualized and typically initiated at lower doses. The 0.075 mg patch strength is generally too high for initial pediatric use.

πŸ‘΄

Geriatric Use

Use with caution. Women 65 years of age or older may be at increased risk of probable dementia with estrogen therapy. The lowest effective dose for the shortest duration should be used. Monitor closely for cardiovascular events, stroke, and breast cancer. No specific dose adjustment based solely on age, but individual risk factors should be carefully assessed.

Clinical Information

πŸ’Ž

Clinical Pearls

  • Ensure patients understand the twice-weekly application schedule (e.g., change every 3-4 days) and proper patch application technique (clean, dry skin, rotate sites).
  • Emphasize the importance of regular follow-up appointments and screenings (mammograms, pelvic exams) due to the black box warnings.
  • Counsel patients on the signs and symptoms of serious adverse events (e.g., blood clots, stroke, heart attack, breast cancer) and when to seek immediate medical attention.
  • For women with an intact uterus, a progestin must be co-administered to reduce the risk of endometrial hyperplasia and cancer.
  • Transdermal estradiol bypasses first-pass hepatic metabolism, which may result in a more favorable lipid profile and lower risk of venous thromboembolism compared to oral estrogens, though risks still exist.
  • Adherence is crucial for consistent hormone levels and symptom control. Provide clear instructions on what to do if a patch falls off or a dose is missed.
πŸ”„

Alternative Therapies

  • Other systemic estrogen formulations (oral tablets, vaginal rings, gels, sprays)
  • Local vaginal estrogen products (creams, tablets, rings) for isolated vaginal symptoms
  • Non-hormonal therapies for vasomotor symptoms (e.g., SSRIs/SNRIs like paroxetine, venlafaxine; gabapentin; clonidine)
  • Selective Estrogen Receptor Modulators (SERMs) like Ospemifene (for dyspareunia) or Bazedoxifene/Conjugated Estrogens (Duavee, for vasomotor symptoms and osteoporosis prevention)
  • Bisphosphonates or other anti-resorptive agents for osteoporosis prevention/treatment (if HRT is not suitable)
πŸ’°

Cost & Coverage

Average Cost: $100 - $300 per 8 patches (1 month supply)
Generic Available: Yes
Insurance Coverage: Tier 1 or Tier 2 (generics), Tier 3 or higher (brands) depending on insurance plan formulary.
πŸ“š

General Drug Facts

If your symptoms or health issues persist or worsen, it's essential to contact your doctor for further guidance. To ensure your safety, never share your medication with others or take someone else's medication. Some medications may come with an additional patient information leaflet, so be sure to check with your pharmacist for more information. If you have any questions or concerns about this medication, don't hesitate to reach out to your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek medical attention. When seeking help, be prepared to provide details about the overdose, including the medication taken, the amount, and the time it occurred.